Internal Medicine, Endocrinology, Diabetes, & Metabolism · Pomona, NY
NPI
1518051820
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5b Medical Park Dr
Pomona, NY, 10970
Phone (845) 362-3111
Groups this clinician bills Medicare through
Medicare paid, 2024
$192K
8,686 services
Medicare patients, 2024
396
Average age 74
Drug cost, 2024
$3.0M
7,660 prescriptions
Company payments, 2025
$1,230
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carla Iudica-Souza was code 99214 (office e&m - established), 772 times for 359 patients. In total Carla Iudica-Souza billed 8,686 services in 75 codes, and Medicare paid $192K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 772 | 359 | $103.53 | $80K |
| 36415 Venipuncture Blood Collection | Office | 769 | 347 | $8.65 | $6,652 |
| 84443 Clinical Chemistry | Office | 749 | 341 | $16.46 | $12K |
| 84439 Clinical Chemistry | Office | 689 | 314 | $8.84 | $6,091 |
| 80053 Clinical Chemistry | Office | 687 | 316 | $10.35 | $7,110 |
| 83735 Clinical Chemistry | Office | 681 | 312 | $6.57 | $4,474 |
| 83036 Blood Count | Office | 601 | 288 | $9.52 | $5,722 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 561 | 274 | $13.75 | $7,714 |
| 80061 Clinical Chemistry | Office | 522 | 244 | $13.12 | $6,849 |
| 84378 Clinical Chemistry | Office | 390 | 169 | $11.30 | $4,407 |
| 85025 Blood Count | Office | 362 | 177 | $7.61 | $2,755 |
| 83970 Clinical Chemistry | Office | 163 | 78 | $40.45 | $6,593 |
| 86376 Immunoassay | Office | 116 | 74 | $14.26 | $1,654 |
| 82306 Clinical Chemistry | Office | 114 | 108 | $29.01 | $3,307 |
| 86800 Immunoassay | Office | 106 | 72 | $15.59 | $1,653 |
By year: 2022 $180K for 8,265 services; 2023 $192K for 8,480 services; 2024 $192K for 8,686 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 769 | 347 | $8.65 | $6,652 |
| 84443 Clinical Chemistry | 749 | 341 | $16.46 | $12K |
| 84439 Clinical Chemistry | 689 | 314 | $8.84 | $6,091 |
| 80053 Clinical Chemistry | 687 | 316 | $10.35 | $7,110 |
| 83735 Clinical Chemistry | 681 | 312 | $6.57 | $4,474 |
| 83036 Blood Count | 601 | 288 | $9.52 | $5,722 |
| 80061 Clinical Chemistry | 522 | 244 | $13.12 | $6,849 |
| 84378 Clinical Chemistry | 390 | 169 | $11.30 | $4,407 |
| 85025 Blood Count | 362 | 177 | $7.61 | $2,755 |
| 83970 Clinical Chemistry | 163 | 78 | $40.45 | $6,593 |
Medicare prescription drug claims, 2024
In 2024, the drug Carla Iudica-Souza prescribed most often to Medicare patients was Ozempic (Semaglutide), with 587 prescriptions and refills. In total Carla Iudica-Souza wrote 7,660 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 587 | 742 | 110 | $643K |
| Metformin Hcl Er Metformin Hcl | 487 | 1,277 | 144 | $6,456 |
| Levothyroxine Sodium Generic | 483 | 1,232 | 129 | $7,412 |
| Synthroid Levothyroxine Sodium | 474 | 1,206 | 119 | $44K |
| Atorvastatin Calcium Generic | 347 | 941 | 104 | $3,468 |
| Jardiance Empagliflozin | 299 | 732 | 83 | $393K |
| Losartan Potassium Generic | 243 | 667 | 75 | $2,378 |
| Glimepiride Generic | 185 | 474 | 51 | $2,175 |
| Amlodipine Besylate Generic | 184 | 478 | 56 | $1,308 |
| Alendronate Sodium Generic | 175 | 426 | 48 | $1,440 |
| Metformin Hcl Generic | 162 | 442 | 46 | $1,405 |
| Synjardy Empagliflozin/Metformin Hcl | 157 | 409 | 41 | $207K |
| Tresiba Flextouch U-100 Insulin Degludec | 157 | 383 | 54 | $99K |
| Trulicity Dulaglutide | 146 | 310 | 42 | $276K |
| Rosuvastatin Calcium Generic | 140 | 391 | 48 | $2,333 |
Brand drugs: 3,445 claims; generic drugs: 3,881 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carla Iudica-Souza $1,230 ($1,230 in general payments such as food, travel and fees) from 21 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $147.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $147 |
| Lilly USA, LLC LLY | 6 | $109 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $109 |
| Kyowa Kirin, Inc. 4151.T | 4 | $90.8 |
| Novo Nordisk Inc NVO | 5 | $87.02 |
| Amgen Inc. AMGN | 4 | $85.72 |
| Ascendis Pharma Endocrinology Inc ASND | 3 | $67.24 |
| Xeris Pharmaceuticals, Inc. | 3 | $66.5 |
| Chiesi USA, Inc. | 3 | $66.26 |
| Mannkind Corporation MNKD | 3 | $55.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.